Strategy and Planning
Spotlight on Transitions
|This topic of “transition” came home to me (literally and figuratively) over the Thanksgiving holiday. With our adult kids returning, my husband and I decided it was time to have them go through their “bins” and throw out, donate, or take back with them, their childhood. The bins in question are tools we employed over… Read the full article…|
Is Your Networking Not Working?
|Networking! You know, that activity that one either embraces or goes running away from as quickly as possible. For many, the word evokes a grueling, overwhelming, unnatural process, and something that requires stepping way out of one’s comfort zone. But I have two pieces of good news… First, networking is an incredibly effective tool for… Read the full article…|
Optimizing Your Essential Commercialization Teams
|For those of you following closely (thank you!), you may recall that in an earlier e-conversation — 21st Century Commercialization — More than a Point in Time! — we defined commercialization as neither a function nor a process. Rather, we think of it as a “mindset” — something present from the very beginning of product… Read the full article…|
Are Your Assumptions Serving You Well?
|Ah, June, the season of life transitions — weddings, graduations, school progression and, with the year nearly half over, a reminder to reflect on where we have been and where we are going in 2019.I had such an opportunity, recently, as I listened to the commencement speakers at my son, Jonathan’s, college graduation (empty nest, here we come).… Read the full article…|
The Future Is Now
|Back in the early 2000s, I was head of commercial strategy at Millennium Pharmaceuticals in Cambridge, Massachusetts. I remember saying to then CEO, Mark Levin, that we had an opportunity to define how the company vision, “Transcend the Limits of Medicine,”could be translated at the customer level. This was a once-in-a-career role. I was able to surround… Read the full article…|
Living in a Parallel Universe
|Launching a company and drug simultaneously. (What follows is a synopsis of a recent “team development call,” something that occurs at The NemetzGroup over Zoom every other week. During these calls, we select a topic that allows us to enhance our learning, share best practices, and improve our client offerings.) We began by stating the… Read the full article…|
Tales from the Community… Our Readers Speak!
|This e-conversation goes out to about 2,000 people from the industry, our team’s network, and my life. (Thank you LinkedIn.) Over the course of publishing, we have heard from many of you on a broad range of topics. What we have found fascinating is that different topics generate interest with different people (welcome to the… Read the full article…|
Tales from the Healthcare Front Lines
|Each month, you have given our team permission to communicate our views on the biopharma industry, its leadership, and overall commercialization of innovative medicines. We share this perspective with knowledge of a healthcare system based on what we read, hear, and know from personal experience. In our industry, we often talk about innovation, technology, data,… Read the full article…|
Designing Effective Physician Advisory Board Meetings
|Physician advisory board meetings are quite common in our industry — and, done well, they can be very helpful. Convening a face-to-face meeting with a group of expert physicians in a given therapeutic area benefits biopharma companies in several ways. Some of these include: verifying assumptions about unmet medical needs in the market; gaining insight… Read the full article…|
Rare Diseases: Abandon Everything You Think You Know
|“Overcoming the hurdles has built a great faith in me that things can be done to help people with rare diseases. It will drive my optimism forever and my belief in achieving things that seem impossible.” —Henri Termeer, CEO of Genzyme,who launched the first lifesaving treatment, Ceredase, for Gaucher Disease I am and will always… Read the full article…|